The pineal hormone melatonin plays a major role in circadian sleep–wake rhythm in many mammals, including humans. Patients with acute confusional state or delirium, especially those with underlying cognitive impairment, frequently suffer from sleep disturbances and disturbed circadian rhythm. In this review, an overview is given of delirium and delirium symptoms that correspond with symptoms in dementia, such as sundowning, followed by a presentation of the circadian rhythm disorders in delirium in relation to melatonin deficiency. Finally, this review examines the therapeutic benefit of melatonin treatment in disorders related to delirium and dementia, including the placebo-controlled randomized clinical trials addressing this topic.
Get full access to this article
View all access options for this article.
References
1.
GeorgeJ, BleasdaleS, SingletonSJ. Causes and prognosis of delirium in elderly patients admitted to a district general hospital. Age Ageing, 1997; 26:423–427.
2.
ManosPJ, WuR. The duration of delirium in medical and postoperative patients referred for psychiatric consultation. Ann Clin Psychiatry, 1997; 9:219–226.
3.
WitloxJ, EurelingsLS, de JongheJFet al.Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: A meta-analysis. JAMA, 2010; 304:443–451.
4.
FongTG, JonesRN, MarcantonioERet al.Adverse outcomes after hospitalization and delirium in persons with Alzheimer disease. Ann Intern Med, 2012; 156:848–856.
5.
DantzerR, O'ConnorJC, FreundGGet al.From inflammation to sickness and depression: When the immune system subjugates the brain. Nat Rev Neurosci, 2008; 9:46–56.
6.
DantzerR. Cytokine-induced sickness behaviour: A neuroimmune response to activation of innate immunity. Eur J Pharmacol, 2004; 500:399–411.
7.
DantzerR, KonsmanJP, BlutheRMet al.Neural and humoral pathways of communication from the immune system to the brain: Parallel or convergent?Auton Neurosci, 2000; 85:60–65.
PollmacherT, HaackM, SchuldAet al.Low levels of circulating inflammatory cytokines—do they affect human brain functions?Brain Behav Immun, 2002; 16:525–532.
10.
ReichenbergA, YirmiyaR, SchuldAet al.Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry, 2001; 58:445–452.
11.
AnforthHR, BlutheRM, BristowAet al.Biological activity and brain actions of recombinant rat interleukin-1alpha and interleukin-1beta. Eur Cytokine Netw, 1998; 9:279–288.
12.
HaackM, Hinze-SelchD, FenzelTet al.Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: Effects of confounding factors and diagnosis. J Psychiatr Res, 1999; 33:407–418.
13.
MaclullichAM, EdelshainBT, HallRJet al.Cerebrospinal fluid interleukin-8 levels are higher in people with hip fracture with perioperative delirium than in controls. J Am Geriatr Soc, 2011; 59:1151–1153.
14.
StraubRH, SchuldA, MullingtonJet al.The endotoxin-induced increase of cytokines is followed by an increase of cortisol relative to dehydroepiandrosterone (DHEA) in healthy male subjects. J Endocrinol, 2002; 175:467–474.
15.
PearsonA, deVA, MiddletonSDet al.Cerebrospinal fluid cortisol levels are higher in patients with delirium versus controls. BMC Res Notes, 2010; 3:33.
16.
MangoniAA, van MunsterBC, WoodmanRJet al.Measures of anticholinergic drug exposure, serum anticholinergic activity, and all-cause postdischarge mortality in older hospitalized patients with hip fractures. Am J Geriatr Psychiatry, 2012February6, 2013
17.
WillardLB, Hauss-WegrzyniakB, WenkGL. Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats. Neuroscience, 1999; 88:193–200.
18.
WenkGL, WillardLB. The neural mechanisms underlying cholinergic cell death within the basal forebrain. Int J Dev Neurosci, 1998; 16:729–735.
19.
MunsterBC, AronicaE, ZwindermanAHet al.Neuroinflammation in delirium: A postmortem case-control study. Rejuvenation Res, 2011; 14:615–622.
20.
CunninghamC, CampionS, LunnonKet al.Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biol Psychiatry, 2009; 65:304–312.
21.
CunninghamC. Systemic inflammation and delirium: Important co-factors in the progression of dementia. Biochem Soc Trans, 2011; 39:945–953.
22.
FieldRH, GossenA, CunninghamC. Prior pathology in the basal forebrain cholinergic system predisposes to inflammation-induced working memory deficits: Reconciling inflammatory and cholinergic hypotheses of delirium. J Neurosci, 2012; 32:6288–6294.
23.
MurrayC, SandersonDJ, BarkusCet al.Systemic inflammation induces acute working memory deficits in the primed brain: Relevance for delirium. Neurobiol Aging, 2012; 33:603–616.
24.
MarcantonioER, RudolphJL, CulleyDet al.Serum biomarkers for delirium. J Gerontol A Biol Sci Med Sci, 2006; 61:1281–1286.
25.
GodboutJP, ChenJ, AbrahamJet al.Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB J, 2005; 19:1329–1331.
MaclullichAM, FergusonKJ, MillerTet al.Unravelling the pathophysiology of delirium: A focus on the role of aberrant stress responses. J Psychosom Res, 2008; 65:229–238.
28.
GodboutJP, JohnsonRW. Age and neuroinflammation: A lifetime of psychoneuroimmune consequences. Immunol Allergy Clin North Am, 2009; 29:321–337.
JonesRN, FongTG, MetzgerEet al.Aging, brain disease, and reserve: Implications for delirium. Am J Geriatr Psychiatry, 2010; 18:117–127.
32.
EikelenboomP, VeerhuisR, ScheperWet al.The significance of neuroinflammation in understanding Alzheimer's disease. J Neural Transm, 2006; 113:1685–1695.
33.
EikelenboomP, HoogendijkWJ. Do delirium and Alzheimer's dementia share specific pathogenetic mechanisms?Dement Geriatr Cogn Disord, 1999; 10:319–324.
34.
KudohA, IshiharaH, MatsukiA. Response to surgical stress in elderly patients and Alzheimer's disease. Can J Anaesth, 1999; 46:247–252.
35.
GutteridgeJM. Hydroxyl radicals, iron, oxidative stress, and neurodegeneration. Ann NY Acad Sci, 1994; 738:201–213.
36.
NguyenDN, SpapenH, SuFet al.Elevated serum levels of S-100beta protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock. Crit Care Med, 2006; 34:1967–1974.
37.
van MunsterBC, KorevaarJC, KorseCM. et al.Serum S100B in elderly patients with and without delirium. Int J Geriatr Psychiatry, 2010; 25:234–239.
38.
van MunsterBC, KorseCM, de RooijSEet al.Markers of cerebral damage during delirium in elderly patients with hip fracture. BMC Neurol, 2009; 9:21.
39.
van MunsterBC, BisschopPH, ZwindermanAHet al.Cortisol, interleukins and S100B in delirium in the elderly. Brain Cogn, 2010; 74:18–23.
40.
UchikadoH, AkiyamaH, KondoHet al.Activation of vascular endothelial cells and perivascular cells by systemic inflammation-an immunohistochemical study of postmortem human brain tissues. Acta Neuropathol, 2004; 107:341–351.
41.
LemstraAW, Groen in't WoudJC, HoozemansJJet al.Microglia activation in sepsis: A case-control study. J Neuroinflammation, 2007; 4:4.
42.
MargiottaA, BianchettiA, RanieriPet al.Clinical characteristics and risk factors of delirium in demented and not demented elderly medical inpatients. J Nutr Health Aging, 2006; 10:535–539.
43.
EdlundA, LundstromM, SandbergOet al.Symptom profile of delirium in older people with and without dementia. J Geriatr Psychiatry Neurol, 2007; 20:166–171.
44.
deJA, KorevaarJC, van MunsterBCet al.Effectiveness of melatonin treatment on circadian rhythm disturbances in dementia. Are there implications for delirium? A systematic review. Int J Geriatr Psychiatry, 2010; 25:1201–1208.
45.
BrzezinskiA. Melatonin in humans. N Engl J Med, 1997; 336:186–195.
46.
Carrillo-VicoA, CalvoJR, AbreuPet al.Evidence of melatonin synthesis by human lymphocytes and its physiological significance: Possible role as intracrine, autocrine, and/or paracrine substance. FASEB J, 2004; 18:537–539.
RadognaF, NuccitelliS, MengoniFet al.Neuroprotection by melatonin on astrocytoma cell death. Ann NY Acad Sci, 2009; 1171:509–513.
49.
RadognaF, PaternosterL, AlbertiniMCet al.Melatonin as an apoptosis antagonist. Ann NY Acad Sci, 2006; 1090:226–233.
50.
MaurizJL, ColladoPS, VenerosoCet al.A review of the molecular aspects of melatonin's anti-inflammatory actions: Recent insights and new perspectives. J Pineal Res, 2013; 54:1–14.
51.
SewerynekE, MelchiorriD, ReiterRJet al.Lipopolysaccharide-induced hepatotoxicity is inhibited by the antioxidant melatonin. Eur J Pharmacol, 1995; 293:327–334.
52.
SewerynekE, OrtizGG, ReiterRJet al.Lipopolysaccharide-induced DNA damage is greatly reduced in rats treated with the pineal hormone melatonin. Mol Cell Endocrinol, 1996; 117:183–188.
53.
SewerynekE, MelchiorriD, OrtizGGet al.Melatonin reduces H2O2-induced lipid peroxidation in homogenates of different rat brain regions. J Pineal Res, 1995; 19:51–56.
54.
HashimotoK, UedaS, EharaAet al.Neuroprotective effects of melatonin on the nigrostriatal dopamine system in the zitter rat. Neurosci Lett, 2012; 506:79–83.
55.
KimJY, LeeYD, KimBJet al.Melatonin improves inflammatory cytokine profiles in lung inflammation associated with sleep deprivation. Mol Med Report, 2012; 5:1281–1284.
56.
KohPO. Melatonin regulates the calcium-buffering proteins, parvalbumin and hippocalcin, in ischemic brain injury. J Pineal Res, 2012; 53:358–365.
57.
SinghalNK, SrivastavaG, AgrawalSet al.Melatonin as a neuroprotective agent in the rodent models of Parkinson's disease: Is it all set to irrefutable clinical translation?Mol Neurobiol, 2012; 45:186–199.
58.
MagriF, SarraS, CinchettiWet al.Qualitative and quantitative changes of melatonin levels in physiological and pathological aging and in centenarians. J Pineal Res, 2004; 36:256–261.
59.
HaimovI. Melatonin rhythm abnormalities and sleep disorders in the elderly. CNS Spectr, 2001; 6:502–506.
60.
HaimovI, LaudonM, ZisapelNet al.Sleep disorders and melatonin rhythms in elderly people. BMJ, 1994; 309:167.
61.
GuptaN, deJJ, SchieveldJet al.Delirium phenomenology: What can we learn from the symptoms of delirium?J Psychosom Res, 2008; 65:215–222.
62.
ShigetaH, YasuiA, NimuraYet al.Postoperative delirium and melatonin levels in elderly patients. Am J Surg, 2001; 182:449–454.
63.
MiyazakiT, KuwanoH, KatoHet al.Correlation between serum melatonin circadian rhythm and intensive care unit psychosis after thoracic esophagectomy. Surgery, 2003; 133:662–668.
64.
MundiglerG, Delle-KarthG, KorenyMet al.Impaired circadian rhythm of melatonin secretion in sedated critically ill patients with severe sepsis. Crit Care Med, 2002; 30:536–540.
65.
BalanS, LeibovitzA, ZilaSOet al.The relation between the clinical subtypes of delirium and the urinary level of 6-SMT. J Neuropsychiatry Clin Neurosci, 2003; 15:363–366.
66.
van der MastRC, van den BroekWW, FekkesDet al.Delirium after cardiac surgery. The possible role of tryptophan in relation to the other neutral aminoacids. Adv Exp Med Biol, 1996; 398:93–96.
67.
PandharipandePP, MorandiA, AdamsJRet al.Plasma tryptophan and tyrosine levels are independent risk factors for delirium in critically ill patients. Intensive Care Med, 2009; 35:1886–1892.
68.
RobinsonTN, RaeburnCD, AnglesEMet al.Low tryptophan levels are associated with postoperative delirium in the elderly. Am J Surg, 2008; 196:670–674.
69.
deJA, van MunsterBC, FekkesDet al.The tryptophan depletion theory in delirium: Not confirmed in elderly hip fracture patients. Psychosomatics, 2012; 53:236–243.
70.
BourneRS, MillsGH, MinelliC. Melatonin therapy to improve nocturnal sleep in critically ill patients: Encouraging results from a small randomised controlled trial. Crit Care, 2008; 12:R52.
71.
BourneRS, MillsGH. Melatonin: Possible implications for the postoperative and critically ill patient. Intensive Care Med, 2006; 32:371–379.
72.
HananiaM, KitainE. Melatonin for treatment and prevention of postoperative delirium. Anesth Analg, 2002; 94:338–339table.
73.
ShiloL, DaganY, SmorjikYet al.Effect of melatonin on sleep quality of COPD intensive care patients: A pilot study. Chronobiol Int, 2000; 17:71–76.
74.
GarfinkelD, LaudonM, NofDet al.Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet, 1995; 346:541–544.
75.
AsayamaK, YamaderaH, ItoTet al.Double blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia. J Nihon Med Sch, 2003; 70:334–341.
76.
Riemersma-van der LekRF, SwaabDF, TwiskJet al.Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial. JAMA, 2008; 299:2642–2655.
77.
Al-AamaT, BrymerC, GutmanisI. et al.Melatonin decreases delirium in elderly patients: A randomized, placebo-controlled trial. Int J Geriatr Psychiatry, 2011; 26:687–694.
78.
SultanSS. Assessment of role of perioperative melatonin in prevention and treatment of postoperative delirium after hip arthroplasty under spinal anesthesia in the elderly. Saudi J Anaesth, 2010; 4:169–173.
79.
McCuskerJ, ColeM, DendukuriNet al.The course of delirium in older medical inpatients: a prospective study. J Gen Intern Med, 2003; 18:696–704.
80.
SiddiqiK, NewellJ, RobinsonM. Getting evidence into practice: What works in developing countries?Int J Qual Health Care, 2005; 17:447–454.
81.
SiddiqiN, StockdaleR, BrittonAMet al.Interventions for preventing delirium in hospitalised patients. Cochrane Database Syst Rev, 2007; CD005563.
82.
KalisvaartKJ, de JongheJF, BogaardsMJet al.Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: A randomized placebo-controlled study. J Am Geriatr Soc, 2005; 53:1658–1666.
83.
KripkeDF, LangerRD, KlineLE. Hypnotics' association with mortality or cancer: A matched cohort study. BMJ Open, 2012; 2:e000850.
84.
MehtaS, ChenH, JohnsonMLet al.Risk of falls and fractures in older adults using antipsychotic agents: A propensity-matched retrospective cohort study. Drugs Aging, 2010; 27:815–829.
85.
MehtaS, JohnsonML, ChenHet al.Risk of cerebrovascular adverse events in older adults using antipsychotic agents: A propensity-matched retrospective cohort study. J Clin Psychiatry, 2010; 71:689–698.
86.
KleijerBC, van MarumRJ, EgbertsACet al.Risk of cerebrovascular events in elderly users of antipsychotics. J Psychopharmacol, 2009; 23:909–914.
87.
StollbergerC, HuberJO, FinstererJ. Antipsychotic drugs and QT prolongation. Int Clin Psychopharmacol, 2005; 20:243–251.
88.
de JongheA, van MunsterBC, van OostenHEet al.The effects of melatonin versus placebo on delirium in hip fracture patients: Study protocol of a randomised, placebo-controlled, double blind trial. BMC Geriatr, 2011; 11:34.
89.
MaldonadoJR. Pathoetiological model of delirium: A comprehensive understanding of the neurobiology of delirium and an evidence-based approach to prevention and treatment. Crit Care Clin, 2008; 24:789–856ix.
90.
CunninghamC, SkellyDT. Non-steroidal anti-inflammatory drugs and cognitive function: are prostaglandins at the heart of cognitive impairment in dementia and delirium?J Neuroimmune Pharmacol, 2012; 7:60–73.
91.
MurrayC, SandersonDJ, BarkusCet al.Systemic inflammation induces acute working memory deficits in the primed brain: Relevance for delirium. Neurobiol Aging, 2012; 33:603–616.e3.
92.
OsseRJ, TulenJH, HengeveldMWet al.Screening methods for delirium: early diagnosis by means of objective quantification of motor activity patterns using wrist-actigraphy. Interact Cardiovasc Thorac Surg, 2009; 8:344–348.
93.
OsseRJ, TulenJH, BogersAJet al.Disturbed circadian motor activity patterns in postcardiotomy delirium. Psychiatry Clin Neurosci, 2009; 63:56–64.
94.
van UitertUM, de JongheA, de GijselSet al.Rest-activity patterns in patients with delirium. Rejuvenation Res, 2011; 14:483–490.
